Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Medicine.
Press releases published on August 19, 2025
US Navy Veterans Lung Cancer Advocate Urges the Family of a Navy Veteran with Lung Cancer Who Was Exposed to Asbestos Before 1983 on a Ship, Submarine or Shipyard to Call About Compensation-It Might Be Significant
EIN Presswire
·
August 19, 2025
WASHINGTON , DC, UNITED STATES, August 19, 2025 /EINPresswire.com/ -- The US Navy Veterans Lung Cancer Advocate is the premier advocate for navy veterans who were exposed to asbestos on a navy ship, submarine or at a shipyard before 1983 and who now have …
Plant-Based APIs and Natural Extracts Drive Pharmaceutical Advancements in the EAEU
EIN Presswire
·
August 19, 2025
UNITED ARAB EMIRATES, August 19, 2025 /EINPresswire.com/ -- As the pharmaceutical industry increasingly turns to nature for innovative drug solutions, the market for plant-based active pharmaceutical ingredients (APIs) and natural extracts is surging …
Neonatal and Pediatric Hospitalist Dr. Gabriella Dauer Shares Her Top Tips for Beating Back-to-School Bugs on YourUpdateTV
GlobeNewswire
·
August 19, 2025
From hygiene habits to trusted remedies like Mucinex, learn why early prevention is key as kids head back to school NEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Backpacks, new shoes, and fresh routines mark the start of a new school year—but it’s also prime …
Endocrinology Drugs Market to Hit USD 29.88 Billion by 2032, expected to grow at a CAGR of 7.8% from 2025 to 2032
EIN Presswire
·
August 19, 2025
Endocrinology Drugs revenue is expected to grow at a CAGR of 7.8% from 2025 to 2032, reaching nearly USD 29.88 Bn. by 2032. ORLANDO, FL, UNITED STATES, August 19, 2025 /EINPresswire.com/ -- Stellar Market Research examines the growth rate of the …
NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
GlobeNewswire
·
August 19, 2025
EMERYVILLE, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces it has entered into a $6 million securities purchase agreement with private investor David E. Lazar for the …
![[Latest 2025 PDF] Malic Acid Market Size to Surpass USD 279.8 Million by 2031](https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/23574040-malic-acid-market-analysis-109x61.png)
[Latest 2025 PDF] Malic Acid Market Size to Surpass USD 279.8 Million by 2031
EIN Presswire
·
August 19, 2025
The global malic acid market is projected to reach $279.8 million by 2031, growing at a CAGR of 4.1% from 2022 to 2031. WILMINGTON, DE, UNITED STATES, August 19, 2025 /EINPresswire.com/ -- According to the report published by Allied Market Research, the …
Gonorrhea Diagnostic Market Poised to Grow at a CAGR of 6.5% to Reach USD 19.14 Billion by 2032
EIN Presswire
·
August 19, 2025
Gonorrhea Diagnostic Revenue Is Expected To Grow At A CAGR Of 6.5% From 2025 To 2032, Reaching Nearly USD 19.14 Bn. By 2032. SAN DIEGO, CA, UNITED STATES, August 19, 2025 /EINPresswire.com/ -- Stellar Market Research examines the growth rate of the …
Dr. Sam Speron Announces New Treatment for Scars Called 'Scar-Tox
EIN Presswire
·
August 19, 2025
Dr. Sam Speron Announces New Treatment for Scars Called 'Scar-Tox CHICAGO, IL, UNITED STATES, August 19, 2025 /EINPresswire.com/ -- Dr. Sam Speron, a board-certified plastic and reconstructive surgeon, proudly offers 'Scar-Tox,' an innovative treatment …
Beat The Heat: Sleep, Health and Safety in Hot Weather and Heatwaves For Babies and Pregnant Mothers
EIN Presswire
·
August 19, 2025
Eline Holvoet, MD and Baby‑Sleep‑Advice.com Unite on WARM Study to Shield Families from Heat‑Health Risks BRUSSELS, BELGIUM, August 19, 2025 /EINPresswire.com/ -- Baby‑Sleep‑Advice.com, the premier source for truly-no-tears, research‑based infant and …
Scientific Industries Reports Financial Results for Second Quarter of Fiscal Year 2025
GlobeNewswire
·
August 19, 2025
TORBAL DIVISION SALES UP 11% SECURED $10 MILLION IN STRATEGIC DIVESTURE OF GENIE PRODUCT LINE VIVID AND BIOPROCESSING NEW PRODUCT AI ROADMAP ON TARGET Investor Call to be held Wednesday, August 20th at 11:00 a.m. Eastern Time BOHEMIA, N.Y., Aug. 19, 2025 ( …
Nanocellulose Materials Market Growing at a CAGR of 20.1% by 2031 | Increasing demand in Modern Industry
EIN Presswire
·
August 19, 2025
The global nanocellulose materials market is projected to reach $2.2 billion by 2031, growing at a CAGR of 20.1% from 2022 to 2031. WILMINGTON, DE, UNITED STATES, August 19, 2025 /EINPresswire.com/ -- Allied Market Research published a report, titled, " …
Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update
GlobeNewswire
·
August 19, 2025
Quarter highlighted by the key acquisition of The Sleep Center of Nevada, which is generating revenue and seeing strong patient demand for Vivos’ differentiated array of highly effective OSA treatments Management to Host Conference Call today at 5:00 pm ET …
Taazaa Pulls Off Hat Trick, Makes Inc. 5000 List for Third Year
EIN Presswire
·
August 19, 2025
Taazaa continues its growth momentum by delivering innovative software solutions that drive impact for mission-driven organizations. HUDSON, OH, UNITED STATES, August 19, 2025 /EINPresswire.com/ -- Inc. announced today that Taazaa Inc. has made the …
Earth Science Tech, Inc. Board of Directors Approves Reduction of Authorized Common Stock
GlobeNewswire
·
August 19, 2025
Miami, Fla., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential businesses, today announced that its Board of Directors has approved …
Madrigal Receives European Commission Approval for Rezdiffra™ (resmetirom) for the Treatment of MASH with Moderate to Advanced Liver Fibrosis
GlobeNewswire
·
August 19, 2025
Rezdiffra is the first and only medication approved for people living with MASH in the European Union Conditional marketing authorization is based on positive results from the pivotal Phase 3 MAESTRO-NASH trial demonstrating Rezdiffra reduced fibrosis, …
Celldex Reports Results from Phase 2 Study of Barzolvolimab in Eosinophilic Esophagitis (EoE)
GlobeNewswire
·
August 19, 2025
Study met primary endpoint demonstrating barzolvolimab’s ability to potently deplete mast cells in the gastrointestinal tract Profound mast cell depletion did not result in improved clinical outcomes providing direct evidence that mast cells are not a …
Arcutis to Present at Upcoming Investor Conferences
GlobeNewswire
·
August 19, 2025
WESTLAKE VILLAGE, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis …
Ligand to Participate in September Investor Conferences
GlobeNewswire
·
August 19, 2025
JUPITER, Fla., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo Espinoza will participate in the following upcoming investor …
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 19, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on August 15, 2025 it granted stock options to purchase an aggregate of 105,169 shares of common stock and 70,879 restricted stock …
NMDP Announces Nationwide Celebration and Fundraiser to Help Patients in Need of Life-Saving Cell Therapy
GlobeNewswire
·
August 19, 2025
MINNEAPOLIS, Aug. 19, 2025 (GLOBE NEWSWIRE) -- NMDP℠ (formerly Be The Match®), a global nonprofit leader in cell therapy, invites communities nationwide to join NMDP Unite: a community celebration to find cures and save lives. This free, family-friendly …